PMC:7376845 / 590-819 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T4","span":{"begin":147,"end":154},"obj":"Body_part"},{"id":"T5","span":{"begin":209,"end":216},"obj":"Body_part"}],"attributes":[{"id":"A4","pred":"fma_id","subj":"T4","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A5","pred":"fma_id","subj":"T5","obj":"http://purl.org/sig/ont/fma/fma67257"}],"text":"ACE2, appear conserved in SARS-CoV-2.\n\nAim\nThe cross-reactivity with SARS-CoV-2 of monoclonal antibodies (mAbs) previously generated against the S protein of SARS-CoV-1 was assessed.\n\nMethods\nThe SARS-CoV-2 S protein sequence was"}

{"project":"LitCovid-PubTator","denotations":[{"id":"20","span":{"begin":0,"end":4},"obj":"Gene"},{"id":"27","span":{"begin":26,"end":36},"obj":"Species"},{"id":"33","span":{"begin":145,"end":146},"obj":"Gene"},{"id":"34","span":{"begin":158,"end":166},"obj":"Species"},{"id":"35","span":{"begin":69,"end":79},"obj":"Species"},{"id":"46","span":{"begin":196,"end":206},"obj":"Species"}],"attributes":[{"id":"A20","pred":"tao:has_database_id","subj":"20","obj":"Gene:59272"},{"id":"A27","pred":"tao:has_database_id","subj":"27","obj":"Tax:2697049"},{"id":"A33","pred":"tao:has_database_id","subj":"33","obj":"Gene:43740568"},{"id":"A34","pred":"tao:has_database_id","subj":"34","obj":"Tax:694009"},{"id":"A35","pred":"tao:has_database_id","subj":"35","obj":"Tax:2697049"},{"id":"A46","pred":"tao:has_database_id","subj":"46","obj":"Tax:2697049"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"ACE2, appear conserved in SARS-CoV-2.\n\nAim\nThe cross-reactivity with SARS-CoV-2 of monoclonal antibodies (mAbs) previously generated against the S protein of SARS-CoV-1 was assessed.\n\nMethods\nThe SARS-CoV-2 S protein sequence was"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T17","span":{"begin":26,"end":34},"obj":"Disease"},{"id":"T18","span":{"begin":26,"end":30},"obj":"Disease"},{"id":"T19","span":{"begin":69,"end":77},"obj":"Disease"},{"id":"T20","span":{"begin":69,"end":73},"obj":"Disease"},{"id":"T21","span":{"begin":158,"end":166},"obj":"Disease"},{"id":"T22","span":{"begin":158,"end":162},"obj":"Disease"},{"id":"T23","span":{"begin":196,"end":204},"obj":"Disease"},{"id":"T24","span":{"begin":196,"end":200},"obj":"Disease"}],"attributes":[{"id":"A17","pred":"mondo_id","subj":"T17","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A18","pred":"mondo_id","subj":"T18","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A19","pred":"mondo_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A20","pred":"mondo_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A21","pred":"mondo_id","subj":"T21","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A22","pred":"mondo_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A23","pred":"mondo_id","subj":"T23","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"},{"id":"A24","pred":"mondo_id","subj":"T24","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"ACE2, appear conserved in SARS-CoV-2.\n\nAim\nThe cross-reactivity with SARS-CoV-2 of monoclonal antibodies (mAbs) previously generated against the S protein of SARS-CoV-1 was assessed.\n\nMethods\nThe SARS-CoV-2 S protein sequence was"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T7","span":{"begin":39,"end":42},"obj":"http://purl.obolibrary.org/obo/PR_000001343"}],"text":"ACE2, appear conserved in SARS-CoV-2.\n\nAim\nThe cross-reactivity with SARS-CoV-2 of monoclonal antibodies (mAbs) previously generated against the S protein of SARS-CoV-1 was assessed.\n\nMethods\nThe SARS-CoV-2 S protein sequence was"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T5","span":{"begin":147,"end":154},"obj":"Chemical"},{"id":"T6","span":{"begin":209,"end":216},"obj":"Chemical"}],"attributes":[{"id":"A5","pred":"chebi_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A6","pred":"chebi_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"}],"text":"ACE2, appear conserved in SARS-CoV-2.\n\nAim\nThe cross-reactivity with SARS-CoV-2 of monoclonal antibodies (mAbs) previously generated against the S protein of SARS-CoV-1 was assessed.\n\nMethods\nThe SARS-CoV-2 S protein sequence was"}

{"project":"LitCovid-sentences","denotations":[{"id":"T7","span":{"begin":39,"end":42},"obj":"Sentence"},{"id":"T8","span":{"begin":43,"end":182},"obj":"Sentence"},{"id":"T9","span":{"begin":184,"end":191},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"ACE2, appear conserved in SARS-CoV-2.\n\nAim\nThe cross-reactivity with SARS-CoV-2 of monoclonal antibodies (mAbs) previously generated against the S protein of SARS-CoV-1 was assessed.\n\nMethods\nThe SARS-CoV-2 S protein sequence was"}